Press Release: Oak enters battle against malaria

Fresh from PR Log: Oxnard, CA – Oxnard-based pharmaceutical start-up Oak Therapeutics successfully concluded the pre-clinical phase of its anti-malarial medication Artelutrine™. Artelutrine™ is a reformulation of a highly effective, WHO-recommended combination therapy of the active ingredients Artemether and Lumefantrine using Oak Therapeutics novel delivery system, oral dissolvable strips (ODS).

#malaria #oak #study #artemether #lumefantrine

Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

 31416 Agoura Rd. Ste. 105, Westlake Village, CA 91361 and2029 Becker Drive, Lawrence, KS 66047, United States

Tel. +1-913-346-0990, Email: office@oaktherapeutics.com